FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileSawai Group Holdings Co., Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
SWGHF
Sawai Group Holdings Co., Ltd. Stock AnalysisComprehensive stock analysis for Sawai Group Holdings Co., Ltd. (SWGHF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSWGHF
SWGHF
Sawai Group Holdings Co., Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
SWGHF
  1. Home
  2. Stocks
  3. Sawai Group Holdings Co., Ltd.
SW

Sawai Group Holdings Co., Ltd.

🇺🇸SWGHF•OTC
SW

Sawai Group Holdings Co., Ltd.

🇺🇸SWGHF•OTC
Market cap
$1.33B
P/E ratio
18.45

Your view on SWGHF

Mkt Cap
$1.33B
P/E
18.45
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Sawai Group Holdings Co., Ltd.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Mitsuo Sawai
Headquarters
5-2-30, Miyahara, Osaka, JP
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Mitsuo Sawai
Headquarters
5-2-30, Miyahara, Osaka, JP
Description

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research, development, manufacturing, and marketing of generic pharmaceutical products primarily in Japan and the United States.

The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, granules, capsules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms in the therapeutic areas of cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, chemotherapeutic agents, etc., as well as vitamin preparations.

It sells its generic drugs to distributors, wholesalers, and retailers in Japan and the United States. The company was founded in 1929 and is headquartered in Osaka, Japan.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Sawai Group Holdings Co., Ltd.. Starting points for Sawai Group Holdings Co., Ltd.: P/E 18.4, EPS $87.16, beta 0.04 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Sawai Group Holdings Co., Ltd.. Sawai Group Holdings Co., Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Sawai Group Holdings Co., Ltd.. Trailing twelve-month EPS for Sawai Group Holdings Co., Ltd. stands at $87.16. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterMar 2027This yearYear to Mar 2027Next yearYear to Mar 2028
Average estimateJPY 62.65JPY 15.15JPY 133.20JPY 152.95
Lowest estimateJPY 60.00JPY 14.51JPY 128.30JPY 147.33
Highest estimateJPY 65.57JPY 15.86JPY 138.65JPY 159.21
Number of analysts1111
A year agoJPY 0.271−JPY 0.021JPY 91.071—
Growth vs a year ago————

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterMar 2027This yearYear to Mar 2027Next yearYear to Mar 2028
Average estimateJPY 58.59BJPY 50.18BJPY 210.68BJPY 222.06B
Lowest estimateJPY 56.77BJPY 48.48BJPY 206.37BJPY 214.13B
Highest estimateJPY 59.75BJPY 52.93BJPY 215.74BJPY 230.63B
Number of analysts4499
A year agoJPY 56.07BJPY 47.11BJPY 202.95B—
Growth vs a year ago+4.5%+6.5%+3.8%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Sawai Group Holdings Co., Ltd.. Sawai Group Holdings Co., Ltd. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold SWGHF12 companies
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
HEMPHemp, IncHealthcareOTC$882,950
HENCHero Technologies Inc.HealthcareOTC$55,269
HKMPFHikma Pharmaceuticals PLCHealthcareOTC$4.8B
HKMPYHikma Pharmaceuticals PLCHealthcareOTC$5.0B
HLBBFH. Lundbeck A/SHealthcareOTC$4.9B
HLNHaleon plcHealthcareNYSE$39.8B
HLNCFHaleon plcHealthcareOTC$46.5B
HLS.TOHLS Therapeutics Inc.HealthcareTSX$112.9M
HLTRFHLS Therapeutics Inc.HealthcareOTC$105.1M
HLUBFH. Lundbeck A/SHealthcareOTC$5.8B
HMDCFHutchison China Ltd.HealthcareOTC$2.6B
HMPQHempAmericana, IncHealthcareOTC$291,753
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Sawai Group Holdings Co., Ltd.

SWGHF AnalysisWeak
Past
2
Growth
1
Health
3
Profit
0
Value
2